Drugs News and Research

RSS

Queensway Carleton Hospital staff to protest against Liberal government's budget cuts

Staff of the Queensway Carleton Hospital represented by CUPE will protest at lunchtime today over $5,000,000 in budget cuts imposed by the provincial Liberal government.

24 Aug 2010

Men who get genital piercings not strange or aberrant: Study

A new study by researchers at Texas Tech University and the Texas Tech University Health Sciences Center found that the average man with a genital piercing is 31, white, heterosexual, college-educated and earns more than $36,000 a year.

24 Aug 2010

Asian-Americans subgroups lack data on cardiovascular disease

Asians are the fastest-growing racial/ethnic group in the U.S., but data on cardiovascular disease is lacking. There are marked differences in heart disease risk and occurrence among Asian-American subgroups, but data on these subgroups is limited, prompting the American Heart Association to call for more research on this fastest-growing racial/ethnic group in the U.S., according to a scientific statement published in Circulation: Journal of the American Heart Association.

24 Aug 2010

Gold Standard/Elsevier launches consumer medication information in 12 foreign languages

Gold Standard/Elsevier, a leading developer of drug information and medication management solutions, announced today the launch of MEDcounselor Languages, a module that provides trusted MEDcounselor consumer medication information in 12 foreign languages. The new MEDcounselor Languages will enable healthcare providers to help non-English speaking patients better understand their drug therapy, take their medications safely, and avoid potentially harmful errors.

24 Aug 2010

Discovery of Hsp90 protein's pattern of motion paves way for new drug target in cancer therapy

The protein Hsp90 plays a significant role in the survival of cells that are exposed to stress. Researchers at the Technische Universitaet Muenchen (TUM) uncovered this protein's mode of operation some time ago - but now Hsp90 has surprised even the experts with an unexpected pattern of motion. The results are published in the current online issue of the renowned science journal PNAS and may help researchers discover specific cancer medication.

24 Aug 2010

OSDD program aims to develop new drug for tuberculosis

An unlikely effort is underway to lift the veil of nearly-total secrecy that has surrounded the process of developing new prescription drugs for the last century, scientists said today at the 240th National Meeting of the American Chemical Society (ACS). The upheaval in traditional practice would make key data available to college students, university professors, and others in an open, collective process.

24 Aug 2010

Removing corticosteroid regimen after surgery results in better graft survival rates

University of Cincinnati (UC) analysis of 10 years of data from local kidney transplant patients shows that patients removed from a corticosteroid regimen shortly after surgery have better graft survival rates, better survival rates and fewer cardiovascular events than patients kept on the traditional regimen of long-term steroids.

24 Aug 2010

AP reports on efforts to monitor authenticity of antimalarials, other drugs in Africa

The Associated Press reports on a recent effort to use text messages to track the authenticity of antimalarials in Africa, where "more than 30 percent of malaria medicines are estimated to be fake."

24 Aug 2010

Specific drugs can prevent lethal effects of Parkinson's disease: Research

Researchers at Johns Hopkins have shown that using specific drugs can protect nerve cells in mice from the lethal effects of Parkinson's disease. The researchers' findings are published in the August 22 issue of Nature Medicine.

24 Aug 2010

Scientists develop nano-sized vehicle to deliver chemotherapy drugs directly into cancer cells

Chemotherapy, while an effective cancer treatment, also brings debilitating side effects such as nausea, liver toxicity and a battered immune system.Now, a new way to deliver this life-saving therapy to cancer patients getting straight to the source of the disease.

24 Aug 2010

Researchers find new drug to treat circadian rhythm disorders

Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Medical Research Council (MRC) have successfully used a drug to reset and restart the natural 24 hour body clock of mice in the lab. The ability to do this in a mammal opens up the possibility of dealing with a range of human difficulties including some psychiatric disorders, jet lag and the health impacts of shift work.

24 Aug 2010

Alpha-synuclein gene silencing effective for treating neurodegenerative disorders: Research

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators at The Parkinson's Institute and the Mayo Clinic have published new research findings in the journal Public Library of Science (PLoS). The new data show effective silencing of the alpha-synuclein gene with an RNAi therapeutic administered directly to the substantia nigra in the CNS of non-human primates.

24 Aug 2010

Preclinical studies of BIND-014 to be presented at ACS National Meeting

BIND Biosciences announced today the presentation of its Medicinal Nanoengineering platform at the ACS National Meeting, including results from preclinical studies on its lead nanomedicine drug , BIND-014, scheduled to enter clinical trials later this year. BIND-014 is a targeted, polymeric nanoparticle containing the cytotoxic agent, docetaxel, which is approved in major cancer indications, including breast, prostate and lung.

23 Aug 2010

Brain can act as a hiding place for HIV virus: Study

Studies of the spinal fluid of patients given anti-HIV drugs have resulted in new findings suggesting that the brain can act as a hiding place for the HIV virus. Around 10% of patients showed traces of the virus in their spinal fluid but not in their blood.

23 Aug 2010

New antisense drugs may help treat accidental infections: Study

New studies show that treatments targeting specific viral genes protected monkeys infected with deadly Ebola or Marburg viruses. Furthermore, the animals were protected even when therapeutics were administered one hour after exposure-suggesting the approach holds promise for treating accidental infections in laboratory or hospital settings.

23 Aug 2010

Researchers find new way to study oncogene's role in DNA repair

A key step in understanding the origins of familial breast cancer has been made by two teams of scientists at the University of California, Davis. The researchers have purified, for the first time, the protein produced by the breast cancer susceptibility gene BRCA2 and used it to study the oncogene's role in DNA repair.

23 Aug 2010

GM-CSF protein reduces AD pathology, reverses memory loss: Study

A signaling protein released during rheumatoid arthritis dramatically reduced Alzheimer's disease pathology and reversed the memory impairment of mice bred to develop symptoms of the neurodegenerative disease, a new study by the University of South Florida reports. Researchers found that the protein, GM-CSF, likely stimulates the body's natural scavenger cells to attack and remove Alzheimer's amyloid deposits in the brain.

23 Aug 2010

New diagnostic tool proves cost-effective in identifying rare genetic disorders

Mutations in a single gene can cause several types of developmental brain abnormalities that experts have traditionally considered different disorders. With support from the National Institutes of Health, researchers found those mutations through whole exome sequencing - a new gene scanning technology that cuts the cost and time of searching for rare mutations.

23 Aug 2010

HHS Secretary releases review of new federal approach to medical countermeasures

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today released an examination of the federal government's system to produce medications, vaccines, equipment and supplies needed for a health emergency, known as medical countermeasures. The Public Health Emergency Medical Countermeasure Enterprise Review: Transforming the Enterprise to Meet Long Range National Needs reviews the process and makes recommendations for a better approach.

21 Aug 2010

US oncology announces its contributions in development of 42 novel cancer therapies

US Oncology, Inc., the nation's leading integrated oncology company, announced today that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration.

21 Aug 2010

Drugs News and Research

Queensway Carleton Hospital staff to protest against Liberal government's budget cuts

Men who get genital piercings not strange or aberrant: Study

Asian-Americans subgroups lack data on cardiovascular disease

Gold Standard/Elsevier launches consumer medication information in 12 foreign languages

Discovery of Hsp90 protein's pattern of motion paves way for new drug target in cancer therapy

OSDD program aims to develop new drug for tuberculosis

Removing corticosteroid regimen after surgery results in better graft survival rates

AP reports on efforts to monitor authenticity of antimalarials, other drugs in Africa

Specific drugs can prevent lethal effects of Parkinson's disease: Research

Scientists develop nano-sized vehicle to deliver chemotherapy drugs directly into cancer cells

Researchers find new drug to treat circadian rhythm disorders

Alpha-synuclein gene silencing effective for treating neurodegenerative disorders: Research

Preclinical studies of BIND-014 to be presented at ACS National Meeting

Brain can act as a hiding place for HIV virus: Study

New antisense drugs may help treat accidental infections: Study

Researchers find new way to study oncogene's role in DNA repair

GM-CSF protein reduces AD pathology, reverses memory loss: Study

New diagnostic tool proves cost-effective in identifying rare genetic disorders

HHS Secretary releases review of new federal approach to medical countermeasures

US oncology announces its contributions in development of 42 novel cancer therapies

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News